| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |